Terrance Dyer Sells 496 Shares of Ingevity (NYSE:NGVT) Stock

Ingevity Corporation (NYSE:NGVTGet Free Report) SVP Terrance Dyer sold 496 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total transaction of $33,971.04. Following the transaction, the senior vice president directly owned 7,202 shares of the company’s stock, valued at $493,264.98. The trade was a 6.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Ingevity Stock Up 0.9%

Shares of NYSE NGVT opened at $67.18 on Wednesday. The company has a quick ratio of 0.92, a current ratio of 1.42 and a debt-to-equity ratio of 27.83. The business’s 50 day moving average is $71.66 and its two-hundred day moving average is $65.98. Ingevity Corporation has a 52-week low of $39.74 and a 52-week high of $79.29. The firm has a market cap of $2.34 billion, a price-to-earnings ratio of -18.92 and a beta of 1.18.

Ingevity (NYSE:NGVTGet Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.31. Ingevity had a positive return on equity of 207.82% and a negative net margin of 10.55%.The business had revenue of $258.00 million during the quarter, compared to analysts’ expectations of $254.73 million. During the same period in the previous year, the firm posted $1.01 earnings per share. The company’s revenue was up 4.1% on a year-over-year basis. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. Research analysts predict that Ingevity Corporation will post 5.05 EPS for the current year.

Institutional Investors Weigh In On Ingevity

A number of large investors have recently modified their holdings of the company. Global Retirement Partners LLC purchased a new stake in shares of Ingevity during the 4th quarter worth $27,000. Oakworth Capital Inc. purchased a new position in Ingevity in the third quarter valued at $28,000. Meeder Asset Management Inc. acquired a new stake in Ingevity in the fourth quarter valued at $33,000. Geneos Wealth Management Inc. lifted its holdings in Ingevity by 85.8% during the 2nd quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after buying an additional 387 shares during the last quarter. Finally, Headlands Technologies LLC acquired a new position in shares of Ingevity during the 2nd quarter worth about $46,000. 91.59% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on the stock. Wells Fargo & Company raised their price objective on shares of Ingevity from $65.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, February 27th. BMO Capital Markets reissued an “outperform” rating and issued a $83.00 price target on shares of Ingevity in a research report on Monday, March 2nd. Wall Street Zen upgraded shares of Ingevity from a “hold” rating to a “strong-buy” rating in a research note on Saturday, May 9th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ingevity in a research note on Tuesday, April 21st. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $82.00 target price on shares of Ingevity in a report on Thursday, February 26th. Two analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $80.00.

Get Our Latest Report on Ingevity

Ingevity Company Profile

(Get Free Report)

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

Further Reading

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.